DBDeep Birjani

Deep Birjani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Deep Birjani has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Burden of Pneumonia- and Malnutrition-Associated Mortality Among U.S. Adults Aged 65 Years and Older, 1999–2020

    by Ayesha Ahmed, Deep Birjani, Maryam Ahmed, Unaisa Ishaq, Zafir Ashar Siddiqui, Muhammad Salman Mustafa, Muhammad Sameer Khan

    Pneumonia and malnutrition are major contributors to mortality among older adults, yet their combined population-level burden remains poorly defined. We examined national trends and sociodemographic disparities in pneumonia and malnutrition-associated mortality among adults aged 65 years and older in the United States by analyzing data from the CDC WONDER Multiple Cause of Death database from 1999 to 2020. Age-adjusted mortality rates (AAMR) per 100,000 population were calculated, and temporal trends were assessed using Joinpoint regression. Between 1999 and 2020, 81,753 deaths involving both conditions occurred. The overall AAMR declined from 13.82 to 11.90 per 100,000, though a sharp increase occurred from 2017 to 2020. Mortality rates were higher among males, adults aged 85 and older, American Indian/Alaska Native and Black individuals, nonmetropolitan populations, and residents in the South, with Texas exhibiting the highest state-level rate. Pneumonia and malnutrition-associated mortality among older U.S. adults declined over much of the study period but increased substantially in recent years. Persistent demographic and geographic disparities suggest that vulnerable older adults remain at elevated risk, highlighting the need for integrated pneumonia prevention, nutritional screening, and targeted early interventions.

  • Open Access

    Clinical Outcomes of Pulsed Field Vs. Thermal Ablation for Paroxysmal Atrial Fibrillation: Systematic Review and Meta‐Analysis of Randomized Evidence

    by Asad Ali Ahmed Cheema, Reshail Asif, Unsa Arif, Manahil Malik, Sarah Misbah, Eraj Nadeem, Muhammad Iftikhar Alam, Deep Birjani, Syed Umair Ahmed, Fnu Hamna, et al.

    Aims: Pulsed field ablation (PFA) is a non‐thermal alternative to conventional thermal ablation for paroxysmal atrial fibrillation (AF). We conducted an updated systematic review and meta‐analysis of randomized evidence comparing efficacy, safety, and procedural outcomes. Methods: PubMed/MEDLINE and the Cochrane Central Register of Controlled Trials were searched from inception through March 2026 for randomized controlled trials (RCTs) comparing PFA with thermal ablation in adults undergoing first catheter ablation for paroxysmal AF. Risk ratios (RRs) or mean differences (MDs) with 95% confidence intervals (CIs) were pooled using random‐effects models. Results: Four RCTs enrolling 1 393 patients were included. PFA showed no statistically detectable difference in 12‐month treatment success (RR, 1.04; 95% CI, 0.97 to 1.12; I 2 = 7%), recurrent atrial arrhythmias (RR, 1.00; 95% CI, 0.77 to 1.29; I 2 = 42%), or composite serious adverse events (RR, 0.71; 95% CI, 0.32 to 1.57; I 2 = 7%). PFA shortened procedure time (MD, −22.42 min; 95% CI, −33.44 to −11.39; I 2 = 91%) and LA dwell time (MD, −25.73 min; 95% CI, −34.66 to −16.79; I 2 = 92%), but increased fluoroscopy time (MD, 7.34 min; 95% CI, 0.39 to 14.30; I 2 = 98%). Conclusions: Across the included trial configurations, 12‐month efficacy estimates did not differ detectably. Sparse safety events and wide confidence intervals precluded equivalence claims. Pooled procedure and LA dwell times favored PFA, but platform, comparator, and workflow heterogeneity limit generalizability. Procedural findings are exploratory and should not be interpreted as direct energy‐specific effects.

  • Open Access

    Trends and disparities in disseminated intravascular coagulation-related mortality among adults aged 25 and above in the U.S., 1999–2020: CDC WONDER insights

    by Muhammad Yousuf Saleem, Muhammad Salman Mustafa, Areeba Shafiq, Sameer Khan, Mudassir Rauf, Hasibullah Aminpoor, Muhammad Bilal Khan, Deep Birjani, Maryam Ahmed, Jazza Amir

    Background: Disseminated intravascular coagulation (DIC) is a severe, life-threatening coagulopathy often secondary to infection, malignancy, or obstetric complications. Despite advances in critical care, national patterns and disparities in DIC-related mortality remain underexplored. Objectives: To examine temporal, demographic, and regional trends in DIC-related mortality among U.S. adults from 1999 to 2020. Methods: Death certificate data were obtained from the CDC WONDER (Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research) database for adults aged ≥ 25 years with DIC listed as an underlying or contributing cause of death. Age-adjusted mortality rates (AAMRs) per 100,000 population and annual percent change (APC) were calculated using Joinpoint regression and stratified by sex, race/ethnicity, age group, urbanization, and region. Results: From 1999 to 2020, 71,241 DIC-related deaths were identified among U.S. adults. The overall AAMR declined from 2.1 per 100,000 in 1999 to 1.6 in 2020. Men had higher mortality than women (1.6 vs. 1.5), and non-Hispanic (NH) Black adults had the highest AAMR (2.8), followed by Hispanic (1.6), and NH White adults (1.4). Mortality was highest among adults ≥ 85 years (6.1), residents of nonmetropolitan areas (1.6), and those in the South (1.6) and Northeast regions (1.5). Conclusions: Following a prolonged decline, DIC-related mortality in U.S. adults has risen since 2017, particularly among men, Black adults, and those in the South and rural areas. Targeted prevention and equitable access to critical care are essential to curb this resurgence.